Recordati Industria Chimica e Farmaceutica S.p.A. (id:4873 REC)
50.50 EUR
Opening hours: 09:00 - 05:30 (Central European Standard Time: 12/24/2024 5:11:37 PM)
Exchange closed, opens in 15 hours 48 minutes
About Recordati Industria Chimica e Farmaceutica S.p.A.
Market Capitalization 10.57B
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
| Headquarters (address) |
Via Matteo Civitali,1 Milan 20148 MI Italy |
| Phone | 39 02 487871 |
| Website | https://www.recordati.com |
| Employees | 4K |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Ticker | REC |
| Exchange | Italian Stock Exchange |
| Currency | EUR |
| 52 week range | 47.28 - 54.80 |
| Market Capitalization | 10.57B |
| Dividend yield forward | 4.76 % |
| Dividend yield forward Italy (ID:74, base:164) | 13.70 % |
| P/E trailing | 25.07 |
| P/E forward | 18.29 |
| Price/Sale | 4.66 |
| Price/Book | 5.57 |
| Beta | 3.00 |
| EPS | 2.02 |
| EPS Italy (ID:74, base:207) | 3.00 |
Dividend growth streak
Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 11.00 years in a row. This is above the 4.499729 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 4.76 years in a row. This is below the 42121.883600 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 4.68 years in a row. This is below the 23.957000 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 5.86 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 13.84 years in a row. This is above the 10.207200 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 59.32 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers General' industry
Self funded year
Recordati Industria Chimica e Farmaceutica S.p.A. years needed to self fund. This is below the 34.112811 year average in the 'Drug Manufacturers General' industry
Dividend growth streak
Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 11.00 years in a row. This is above the 4.499729 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 4.76 years in a row. This is below the 42121.883600 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 4.68 years in a row. This is below the 23.957000 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 5.86 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 13.84 years in a row. This is above the 10.207200 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Recordati Industria Chimica e Farmaceutica S.p.A. has raised their dividend 59.32 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers General' industry
Self funded year
Recordati Industria Chimica e Farmaceutica S.p.A. years needed to self fund. This is below the 34.112811 year average in the 'Drug Manufacturers General' industry